Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models.
about
Depot Typical Antipsychotics versus Oral Atypical Antipsychotics in Relapse Rate Among Patients with Schizophrenia: A Five -Year Historical Cohort StudyThe role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain - a cost-effectiveness comparisonAn intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece.Impact of risperidone long acting injection on resource utilization in psychiatric secondary care.Identifying patient-relevant endpoints among individuals with schizophrenia: an application of patient-centered health technology assessment.Costs and outcomes associated with an aripiprazole add-on or switching open-label study in psychosis.The cost-effectiveness of risperidone long-acting injection in the treatment of schizophrenia.
P2860
Q33834476-98003866-72FE-42B1-90C2-745B583944ACQ34418847-29D3D2A9-94CA-4249-B85C-39C2A1574A9FQ34720828-0D74D3F7-CE7B-4996-95BF-30F4A97B5AF0Q36173759-35F16BAE-FD13-4E76-9F3E-F37E1FF3EFC3Q36198389-286522B6-A674-493A-BB6E-171D1165FBEDQ37097631-AAFD9CB8-E2DD-4AF9-AC5E-F89DFC4B8FD7Q40012236-55FEF57B-4B92-4DC2-8721-73F138F441C3Q42650536-F22B1E95-7C6B-47F9-9E3F-EEAAC9D88A0EQ42659773-2C7A66AD-8E04-4B75-8DA8-E0BDA7A34A71
P2860
Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pharmacoeconomics of long-acti ...... of cost-effectiveness models.
@ast
Pharmacoeconomics of long-acti ...... of cost-effectiveness models.
@en
type
label
Pharmacoeconomics of long-acti ...... of cost-effectiveness models.
@ast
Pharmacoeconomics of long-acti ...... of cost-effectiveness models.
@en
prefLabel
Pharmacoeconomics of long-acti ...... of cost-effectiveness models.
@ast
Pharmacoeconomics of long-acti ...... of cost-effectiveness models.
@en
P2860
P1433
P1476
Pharmacoeconomics of long-acti ...... of cost-effectiveness models.
@en
P2093
Alan Haycox
P2860
P356
10.2165/00019053-200523001-00002
P478
23 Suppl 1
P577
2005-01-01T00:00:00Z
P6179
1048066238